Concepedia

Mengke Niu

MN

15

Publications

1.2K

Citations

14

H-Index

2020

Active since

Affiliations

Huazhong University of Science and Technology(Current)

Tongji Hospital

Shanxi Medical University

Zhejiang University

Wuhan YZY Biopharma (China)

Mengke Niu is an author at Huazhong University of Science and Technology specializing in t cell immunity, tumor immunology, and tumor immunity.

Top concepts

Publications per year

2020–2025

15

Publications

15

The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1

Ming Yi, Jing Zhang, Anping Li et al. · Journal of Hematology & Oncology · 2021 · 239 citations · Full text

Epidemiological trends of women’s cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study

Ming Yi, Tianye Li, Mengke Niu et al. · Biomarker Research · 2021 · 177 citations · Full text

Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors

Ming Yi, Mengke Niu, Yuze Wu et al. · Journal of Hematology & Oncology · 2022 · 170 citations · Full text

Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers

Ming Yi, Mengke Niu, Jing Zhang et al. · Journal of Hematology & Oncology · 2021 · 167 citations · Full text

Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer

Ming Yi, Yuze Wu, Mengke Niu et al. · Journal for ImmunoTherapy of Cancer · 2022 · 143 citations · Full text

Rows per page

1–5 of 15